Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Sutter

Showing results (1-10 of 179) with videos related to

Pageof 18
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2020
A vital gene for modified vaccinia virus Ankara replication in human cellsGerd Sutter
Current Opinion in Virology|June 18, 2017
Editorial overview: Preventive and therapeutic vaccines: Vaccination against viral disease - current advances and challengesRino Rappuoli, Gerd Sutter
Vaccine|March 26, 2013
Protective efficacy of Modified Vaccinia virus Ankara in preclinical studiesAsisa Volz, Gerd Sutter
Methods in Molecular Medicine|September 6, 2003
Live viral vectors: vaccinia virusCaroline Staib, Gerd Sutter
Current Drug Targets. Infectious Disorders|October 8, 2003
Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen deliveryGerd Sutter, Caroline Staib
Human Vaccines|December 1, 2009
Smallpox vaccines: New formulations and revised strategies for vaccinationNir Paran, Gerd Sutter
Clinical and Vaccine Immunology : CVI|April 30, 2015
Use of the LC16m8 Smallpox Vaccine in Immunocompromised Individuals Is Still Too RiskyYehuda L Danon, Gerd Sutter
Expert Review of Vaccines|April 8, 2009
Candidate influenza vaccines based on recombinant modified vaccinia virus AnkaraGuus F Rimmelzwaan, Gerd Sutter
Frontiers in Immunology|August 28, 2020
Combating COVID-19: MVA Vector Vaccines Applied to the Respiratory Tract as Promising Approach Toward Protective Immunity in the LungReinhold Förster, Henrike Fleige, Gerd Sutter
Current Opinion in Biotechnology|November 25, 2004
Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?Ingo Drexler, Caroline Staib, Gerd Sutter
Pageof 18

Showing results (1-10 of 179) with videos related to

Sort By:
Pageof 18
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2020
A vital gene for modified vaccinia virus Ankara replication in human cellsGerd Sutter
Current Opinion in Virology|June 18, 2017
Editorial overview: Preventive and therapeutic vaccines: Vaccination against viral disease - current advances and challengesRino Rappuoli, Gerd Sutter
Vaccine|March 26, 2013
Protective efficacy of Modified Vaccinia virus Ankara in preclinical studiesAsisa Volz, Gerd Sutter
Methods in Molecular Medicine|September 6, 2003
Live viral vectors: vaccinia virusCaroline Staib, Gerd Sutter
Current Drug Targets. Infectious Disorders|October 8, 2003
Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen deliveryGerd Sutter, Caroline Staib
Human Vaccines|December 1, 2009
Smallpox vaccines: New formulations and revised strategies for vaccinationNir Paran, Gerd Sutter
Clinical and Vaccine Immunology : CVI|April 30, 2015
Use of the LC16m8 Smallpox Vaccine in Immunocompromised Individuals Is Still Too RiskyYehuda L Danon, Gerd Sutter
Expert Review of Vaccines|April 8, 2009
Candidate influenza vaccines based on recombinant modified vaccinia virus AnkaraGuus F Rimmelzwaan, Gerd Sutter
Frontiers in Immunology|August 28, 2020
Combating COVID-19: MVA Vector Vaccines Applied to the Respiratory Tract as Promising Approach Toward Protective Immunity in the LungReinhold Förster, Henrike Fleige, Gerd Sutter
Current Opinion in Biotechnology|November 25, 2004
Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?Ingo Drexler, Caroline Staib, Gerd Sutter
Pageof 18